Effective treatment of severe COVID-19 patients with tocilizumab
暂无分享,去创建一个
Xiaohu Zheng | Binqing Fu | Haiming Wei | Yonggang Zhou | Xiuyong Li | Xiaoling Xu | Mingfeng Han | Tiantian Li | Wei Sun | Dongsheng Wang | Yun Yang | Xiaohua Zhang | A. Pan
[1] Xiaohu Zheng,et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients , 2020, National science review.
[2] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[3] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[4] A. M. Leontovich,et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group , 2020 .
[5] Christian Drosten,et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group , 2020, bioRxiv.
[6] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[7] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[8] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[9] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[10] Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia , 2020, Use of Patented Traditional Chinese Medicine against COVID-19.
[11] Ning Wang,et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus , 2017, PLoS pathogens.
[12] M. Morgan,et al. Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells. , 2017, Journal of immunotherapy.
[13] P. Marik,et al. A Descriptive Study , 2015 .
[14] S. Rose-John,et al. Interleukin-6 and its receptors: a highly regulated and dynamic system. , 2014, Cytokine.
[15] E. Choy,et al. Clinical experience of IL-6 blockade in rheumatic diseases - implications on IL-6 biology and disease pathogenesis. , 2014, Seminars in immunology.
[16] Marion P G Koopmans,et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation , 2013, The Lancet Infectious Diseases.
[17] Kwok-Hung Chan,et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. , 2013, The Journal of general virology.
[18] P. Emery,et al. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial , 2013, The Lancet.
[19] Hong Zhou,et al. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response , 2012, Microbes and Infection.
[20] I. Rosner,et al. Tocilizumab - a novel therapy for non-organ-specific autoimmune diseases. , 2012, Best practice & research. Clinical rheumatology.
[21] J. Scheller,et al. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. , 2011, The Journal of clinical investigation.
[22] D. Hamilton. Outbreak Investigation , 2014 .
[23] T. Kishimoto,et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial , 2008, The Lancet.
[24] Guo-Ping Zhao,et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. , 2005, Proceedings of the National Academy of Sciences of the United States of America.